Skip to content

Effecten van oligofructose (OF) supplementen op lichaamsgewicht en lichaamssamenstelling

Oligofructose supplementation in overweight and obese adults: effects on body weight and body composition

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23700
Enrollment
60
Registered
2013-07-15
Start date
2013-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight, Obesity

Interventions

Subjects receive either 16 g oligofructose or no oligofructose daily for 12 weeks. The dietary supplement will be consumed as a granola bar twice a day (8 g of oligofructose or no oligofructose per ba

Sponsors

Wageningen University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Men and women Age 20 – 60 years BMI 25-35 kg/m2 Healthy: as judged by the participant

Exclusion criteria

Exclusion criteria: Reported cardiovascular, liver, pancreas, renal, thyroid or gastrointestinal disease Reported diabetes type 1 Unstable type 2 diabetes, hypertension or dyslipidaemia Medication that can interfere with the experiment (antibiotics, appetite suppressors, weight loss supplements) Gain or loss of more > 5 kg in the 3 months prior to study entry Lack of appetite for any reason Women: pregnant or lactating Fasting glucose concentration >6.9 mmol/l Total cholesterol >6.5 mmol/l Triglycerides >2.2 mmol/l Glucose or protein in urine

Design outcomes

Primary

MeasureTime frame
Difference in change of body weight and fat mass between control and oligofructose group after 12 weeks of supplementation.

Secondary

MeasureTime frame
24-h food intake, 24-h appetite, chronic appetite, physical activity

Contacts

Public ContactMonica Mars

Afdeling Humane Voeding Wageningen Universiteit Postbus 8129.

monica.mars@wur.nl+31 (0)317 485340

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)